INTRODUCTION
FGF-23(Fibroblast growth factor-23) is a key peptide hormone for serum phosphorus regulation (1) . Klotho, produced in osteocysts, is an essential cofactor for FGF-23 receptor activation (2) . Renal transplantation(RTx) is a gold standard treatment modality for end stage renal disease patients. The aim of this study was to measure FGF-23, klotho, calcium, phosphorus, parathormon and 25-OH vitamin D levels in RTx patients, and to compare with hemodialysis patients and healthy controls.
METHOD
The study group composed of 40 RTx patients who had transplantation at least 6 months before. Control groups were 25 hemodialysis patients and 20 healthy subjects. Sociodemografic data of the participants were recorded. Calcium, phosphorus, parathormon, 25-OH vitamin D, FGF-23, klotho, creatinine, uric acid and CRP levels and hemogram were measured. FGF-23 and klotho was studied using Elisa method.
RESULTS
Creatinine (p<0001), uric acid(p=003), phosphorus (p<0001), parathormon (p<0001), FGF-23 (p<0001) and klotho (p<0001) levels were significantly different between groups (Table) . FGF-23 (p=0,52) was not different between RTx group and HD group. However klotho (p=001) was significantly lower in RTx group. When we compare RTx and healthy controls FGF-23 (p<0,0001) was significantly higher and klotho (p=0,022) was lower in RTx group. When we compared HD and healthy controls FGF-23 (p<0001) was higher, klotho(p<0001) was lower in HD group. Correlation analysis revealed that FGF-23 was correlated with klotho (r:0,31 p=0,04), creatinine(r:0,44 p<0,0001), uric acid (r:0,38 p<0,0001) and CRP (r:0,26 p=0,014) levels and klotho was correlated with FGF-23(r:0,31 p=0,04), creatinine (r:0,38 p<0,0001) and phosphorus (r:0,35 p=0,001) levels. 
